Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Cholangiocarcinoma 3Urinary Bladder Neoplasms 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Renal Pelvis and Ureter Urothelial Carcinoma 1Rectal Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Liver Neoplasms 1Glioma 1Glioblastoma 1Colonic Neoplasms 1Breast Neoplasms 1Advanced Gastrointestinal Stromal Tumor (GIST) 1Acrocephalosyndactylia 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 9Papillomavirus Vaccines 8Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 8Surveys and Questionnaires 6Educational Status 6Blood Specimen Collection 5Vaginal Smears 4Radiotherapy, Intensity-Modulated 4Methods 4Human Papillomavirus DNA Tests 4Early Intervention, Educational 4Cisplatin 4Carboplatin 4Patient Navigation 3Mass Screening 3Taxes 2Standard of Care 2Radiation 2Practice Guidelines as Topic 2Papanicolaou Test 2Paclitaxel 2Motivational Interviewing 2Interviews as Topic 2Electrocoagulation 2Docetaxel 2Cytological Techniques 2Cryotherapy 2Colposcopy 2utomilumab 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Papillomavirus Infections × infigratinib × Clear all
NCT02706691 2019-04-16

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

University of Chicago

Phase 2 Terminated
1 enrolled 8 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡